• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[操作指南:抗心律失常药物的临床应用]

[How to: clinical use of antiarrhythmic drugs].

作者信息

Hillmann Henrike A K, Betz Konstanze, Linz Dominik, Duncker David

机构信息

Hannover Herzrhythmus Centrum, Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.

Department of Cardiology and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, Niederlande.

出版信息

Herzschrittmacherther Elektrophysiol. 2023 Mar;34(1):82-90. doi: 10.1007/s00399-022-00919-y. Epub 2023 Jan 24.

DOI:10.1007/s00399-022-00919-y
PMID:36692540
Abstract

Antiarrhythmic drugs are important for the noninvasive rhythm control therapy of heart rhythm disorders. Antiarrhythmic drugs, which can be categorized into subgroups based on their different effects on ion channels, are clinically used for various types of arrhythmias. Knowledge about these specific electrophysiological effects contributes to a better understanding in order to select the correct drug for each specific arrhythmia. This review summarizes mechanisms, indications, contraindications, and side effects of the different antiarrhythmic drugs and, thus, supports their adequate use in daily clinical routine.

摘要

抗心律失常药物对于心律失常的非侵入性节律控制治疗至关重要。抗心律失常药物可根据其对离子通道的不同作用分为不同亚组,临床上用于治疗各种类型的心律失常。了解这些特定的电生理效应有助于更好地理解,以便为每种特定的心律失常选择正确的药物。本综述总结了不同抗心律失常药物的作用机制、适应证、禁忌证和副作用,从而支持它们在日常临床实践中的合理使用。

相似文献

1
[How to: clinical use of antiarrhythmic drugs].[操作指南:抗心律失常药物的临床应用]
Herzschrittmacherther Elektrophysiol. 2023 Mar;34(1):82-90. doi: 10.1007/s00399-022-00919-y. Epub 2023 Jan 24.
2
[Antiarrhythmic drugs in the present day].[当今的抗心律失常药物]
Inn Med (Heidelb). 2024 Aug;65(8):762-769. doi: 10.1007/s00108-024-01745-9. Epub 2024 Jul 15.
3
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.
4
[Drug therapy of cardiac arrhythmias 199].[心律失常的药物治疗 199]
Fortschr Med. 1997 Nov 30;115(33):32, 34-6, 38.
5
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].[I类抗心律失常药物:作用机制、禁忌证及当前适应证]
Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):228-38. doi: 10.1007/s00399-010-0090-1.
6
[Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].[新型抗心律失常药物治疗心房颤动的基本机制]
Arch Cardiol Mex. 2012 Apr-Jun;82(2):139-52.
7
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者使用的抗心律失常药物。
Am J Cardiovasc Drugs. 2005;5(6):371-8. doi: 10.2165/00129784-200505060-00004.
8
Guidelines for the use of propafenone in treating supraventricular arrhythmias.普罗帕酮治疗室上性心律失常的使用指南。
Drugs. 1995 Aug;50(2):250-62. doi: 10.2165/00003495-199550020-00005.
9
Atria-selective antiarrhythmic drugs in need of alliance partners.需要联盟伙伴的心房选择性抗心律失常药物。
Pharmacol Res. 2019 Jul;145:104262. doi: 10.1016/j.phrs.2019.104262. Epub 2019 May 3.
10
Antiarrhythmic therapy in atrial fibrillation.心房颤动的抗心律失常治疗。
Pharmacol Ther. 2010 Oct;128(1):129-45. doi: 10.1016/j.pharmthera.2010.06.004. Epub 2010 Jul 17.

引用本文的文献

1
Ultra-short-term heart rate variability using a photoplethysmography-based smartphone application: a TeleCheck-AF subanalysis.使用基于光电容积脉搏波描记法的智能手机应用程序进行超短期心率变异性分析:TeleCheck-AF亚组分析
Eur Heart J Digit Health. 2025 Apr 11;6(4):675-682. doi: 10.1093/ehjdh/ztaf035. eCollection 2025 Jul.

本文引用的文献

1
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
2
[Artificial intelligence-based ECG analysis: current status and future perspectives-Part 2 : Recent studies and future].基于人工智能的心电图分析:现状与未来展望 - 第2部分:近期研究与未来
Herzschrittmacherther Elektrophysiol. 2022 Sep;33(3):305-311. doi: 10.1007/s00399-022-00855-x. Epub 2022 May 12.
3
Emerging Antiarrhythmic Drugs for Atrial Fibrillation.
新型抗心律失常药物治疗心房颤动。
Int J Mol Sci. 2022 Apr 7;23(8):4096. doi: 10.3390/ijms23084096.
4
The cardiac autonomic nervous system: an introduction.心脏自主神经系统:简介。
Herzschrittmacherther Elektrophysiol. 2021 Sep;32(3):295-301. doi: 10.1007/s00399-021-00776-1. Epub 2021 Aug 13.
5
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
6
[Emergency management of regular supraventricular tachycardias].[阵发性室上性心动过速的急诊处理]
Herzschrittmacherther Elektrophysiol. 2020 Mar;31(1):10-19. doi: 10.1007/s00399-020-00673-z. Epub 2020 Feb 13.
7
A great first step, but a long way to go.
Eur Heart J. 2019 Oct 1;40(37):3108-3109. doi: 10.1093/eurheartj/ehz596.
8
Modernized Classification of Cardiac Antiarrhythmic Drugs.心脏抗心律失常药物的现代化分类。
Circulation. 2018 Oct 23;138(17):1879-1896. doi: 10.1161/CIRCULATIONAHA.118.035455.
9
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).抗心律失常药物——临床应用与临床决策:欧洲心律协会(EHRA)和欧洲心脏病学会(ESC)心血管药理学工作组的共识文件,得到心律学会(HRS)、亚太心律学会(APHRS)和国际心血管药物治疗学会(ISCP)认可。
Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373.
10
[Brugada syndrome].[布加综合征]
Herzschrittmacherther Elektrophysiol. 2012 Sep;23(3):225-30. doi: 10.1007/s00399-012-0231-9. Epub 2012 Sep 20.